Abstract
Introduction
Since the past two decades, Ir(III) cyclometalated complexes have been in the spotlight of the research programs of many groups worldwide. 1 Such a pronounced and still active scientific interest reflects the multiple applications of this class of compounds in research themes that have in common the study of the interaction of matter with light. Following the fundamental studies centred on the photophysics of Ir(III) cyclometalates, these molecules have emerged as the paradigm of the metal-based phosphors for lighting devices, foldable displays and, in general, for all the applications in which bright and colour tuneable emissions are required. 2 Also, the characteristic photoluminescent output displayed by these molecules has allowed their use as responsive chemosensors, 3 promising photocatalysts 4 and luminescent markers for live cell imaging. Within the framework of our studies dealing with luminescent metal complexes containing 5 aryl tetrazolate ligands, 11 we have dedicated much attention to the corresponding heteroleptic Ir (III) cyclometalates with the general formula Ir(C^N)2(N^N)], 12 where C^N is represented by the cyclometalating 2-phenylpyridine (ppy) or 2-(2,4-difluorophenyl)pyridine (F2ppy) and N^N denotes tetrazolate ligands. The inclusion of these anionic and nitrogen rich ligands in the structure of such Ir(III) chelates led to a family of neutrally charged complexes in which a significant tuning of the luminescence maxima could be accomplished upon simple chemical modulation of the tetrazolato ancillary ligand. In the biological context, we have recently investigated the use of these neutral Ir(III) tetrazolate complexes as luminescent markers for live cells imaging. As a direct comparison,
we have also explored the corresponding cationic complexes that were obtained by irreversible methylation of the neutral iridium species, according to the peculiar reactivity of the coordinated tetrazolate ring toward electrophiles. 12, 13, 14, 15 From this study, an interesting trend has emerged, illustrating how while the neutral iridium complexes display low levels of adverse effects, methylation causes systematic enhancement of cytotoxicity. 16 This behaviour seems to mostly originate from the specific localisation of the iridium complexes within the cells, with the cationic complexes predominantly targeting the mitochondria. Furthering these studies, we have now selected two Ir(III)-tetrazolates (Scheme 1) that display different luminescent outputs and focused our attention to the antibacterial properties of these iridium complexes and in particular, to the potential differences between the neutral and charged species. The results reported herein highlight an analogous behaviour, with a "switch on" of their antimicrobial activity toward Gram (+) Deinococcus radiodurans, which is one of the most resistant bacteria featuring appropriate defence systems against oxidative damage, 17 upon methylation of the parent neutral Ir(III)complexes.
Results and discussion
The synthetic procedure for the preparation of the target complexes is illustrated in Scheme 1. (Figures 1-3) . In all the complexes the tetrazole ring is coordinated through the N-1 position and methylation of (21) 2.026 (19) , Ir(1)-C(32) 1.992(19) , N(1)-N(2) 1.391 (19) , N(2)-N(3) 1.318(19) The neutral and the cationic Ir(III) complexes display very similar absorption profiles, which consist of intense Ligand centred (LC) transitions in the higher energy part of the spectra (up to 300 nm) accompanied by weaker Metal-to-Ligand Charge Transfer (MLCT) processes at longer wavelengths ( Figure 4 ) . Conversely, a dramatically different picture is drawn when the analysis of the emission properties is performed. As we demonstrated earlier, 11-15 indeed, tetrazolate-and tetrazole-based ligands induce a significant influence in determining the photoluminescent output of the corresponding neutral Ir(III) complexes. The occurrence of a similar behaviour is observed also for the complexes described herein. Upon excitation of the corresponding dilute dichloromethane solutions, the neutral complexes (Table 1 ). 
Photophysical properties

Biological activity -antimicrobial properties
Inspired by the recent reports by the groups of Chao 10 and Crowley, 6a we wanted to assess whether or not the conversion of neutral Ir(III) tetrazolates into cationic Ir(III) tetrazole complexes might confer any eventual antimicrobial activity, to be evaluated against Gram negative (Escherichia coli) and Gram positive bacteria (Deinococcus radiodurans).
The effect of the neutral and cationic Ir(III) complexes on bacterial growth was initially screened by performing disk diffusion tests in which ampicillin was used as the positive control. The appearance of inhibition zones around the paper disks soaked with solutions of the metal complexes was examined after incubation of the agar plates at 303 K for a period of 24 hours. As shown in Figure 8 , none of the neutral or cationic Ir(III) complexes, which all display phosphorescent emission originating from excited states with triplet multiplicity, can inhibit the growth of E. coli, as no discernible inhibition zone did appear. A quite different outcome was observed when the same experiments were performed with D. and all cultures showed comparable growth rates. Moreover, the presence of DMSO alone at low concentration, 0.4 or 1.5%, did not affect the growth rate of E. coli (see Figure 10 ). Figure S31 and Table   S6 ). , these results appear congruent with the different size of the inhibition zones that were observed in the agar disks diffusion tests (see Figure 9 ). Finally, our results suggest that the antimicrobial properties of the Ir(III) complexes described herein might be independent from their luminescence features. In particular, the antimicrobial activity towards E. coli and D. radiodurans of the phosphorescent neutral and cationic Ir(III) complexes does not appear to be influenced in any way by the production of reactive oxygen species (ROS) such as singlet oxygen ( 1 O2 Figure S32 and Table S7 ).
Conclusions
The photomultiplier tube (185−850 nm). Emission and excitation spectra were acquired with a cut-off filter (395 nm) and corrected for source intensity (lamp and grating) and emission spectral response (detector and grating) by a calibration curve supplied with the instrument. The wavelengths for the emission and excitation spectra were determined using the absorption maxima of the MLCT transition bands (emission spectra) and at the maxima of the emission bands (excitation spectra). Quantum yields (Φ) were determined using the optically dilute method by spectrometer using pulsed picosecond LED (EPLED 360, FWHM < 800ps) as the excitation source, with repetition rates between 1 kHz and 1 MHz, and the above-mentioned R928P PMT as detector. The goodness of fit was assessed by minimizing the reduced χ2 function and by visual inspection of the weighted residuals. To record the 77 K luminescence spectra, the samples were put in quartz tubes (2 mm diameter) and inserted in a special quartz Dewar filled with liquid nitrogen. The solvent used in the preparation of the solutions for the photophysical investigations was of spectrometric grade. Experimental uncertainties are estimated to be ±8% for lifetime determinations, ±20% for quantum yields, and ±2 nm and ±5 nm for absorption and emission peaks, respectively.
Ligand synthesis
Warning! Tetrazole derivatives are used as components for explosive mixtures. 22 In this lab, the reactions described here were only run on a few grams scale and no problems were encountered.
However, great caution should be exercised when handling or heating compounds of this type.
Following the general method reported by Koguro and co-workers, 23 [F2IrPTZ] 1 H-NMR (CD3CN, 400 MHz) δ (ppm): 8. 38-8.36 (m, 1H); 8.32-8.29 (m, 2H); 8.11-8.07 (m, 1H); 7.90-7.86 (m, 3H); 7.67-7.65 (m, 1H); 7.59-7.56 (m, 1H); 7.41-7.37 (m, 1H); 7.12-7.05 (m, 2H); 6.72-6.60 (m, 2H); 5.86-5.83 (m, 1H); 5.78-5.75 (m, 1H) . 86, 164.17, 164.00, 163.93, 163.86, 162.59, 162.22, 162.08, 161.64, 161.51, 160.13, 160.01, 159.64, 159.51, 156.42, 156.35, 152.17, 157.11, 150.50, 149.75, 149.44, 148.71, 139.98, 139.07, 138.93. Anal. Calcd. For C28H16IrN7F4 (718.68) C 46.8, H 2.24, N 13.64. Found: C 46.34, H 2.24, N 13.21. [IrQTZ] 1 H-NMR (CD3CN, 400 MHz) δ (ppm): 8. 61 -8.53 (m, 2H), 8.06 -8.00 (m, 2H), 7.97 -7.92 (m, 2H), 7.89 -7.87 (m, 1H), 7.81 -7.68 (m, 4H), 7.53 -7.49 (m, 1H), 7.33 -7.32 (m, 1H), 7.19 -7.15 (m, 1H), 7.06 -7.02 (m, 1H), 6.99 -6.93 (m, 3H), 6.90 -6.87 (m, 1H), 6.83 -6.79 (m, 1H), 6.49 -6.48 (m, 1H), 6.15 -6.13 (m, 1H) . 13 C-NMR (CD3CN, 100 MHz) δ (ppm) = 169. 45, 168.55, 166.76 (Ct), 157.09, 155.48, 152.50, 151.96, 150.26, 149.05, 146.01, 145.18, 145.07, 142.16, 139.34, 139.27, 133.48, 132.33, 131.45, 130.82, 130.75, 130.26, 129.12, 129.11, 126.29, 126.17, 125.51, 124.59, 124.34, 123.25, 123.23, 121.20, 120.76 
General Procedure for the Preparation of the Cationic Ir(III) complexes
1 eq of the desired neutral Ir(III) tetrazolate complex was added to dichloromethane and the mixture was allowed to cool down by immersion into an ethanol/liquid nitrogen cold bath. Then, methyl trifluoromethanesulfonate (1.2 equiv., solution in dichloromethane 0.179 M) was added.
The reaction was stirred under nitrogen for 30 minutes while being kept in the cold bath, and then allowed to warm up to room temperature and stirred for 3 hours. Anion exchange was carried out by adding an excess of NH4PF6 in water to the solution and stirring for 20 minutes. The product was then extracted using dichloromethane (3×10 mL) and the organic components were combined and dried over anhydrous MgSO4. Subsequent purification by column chromatography on alumina 167.69, 167.15, 151.08, 149.91, 149.61, 147.95, 146.63, 144.35, 143.83, 142.34, 140.12, 138.84, 138.80, 132.22, 131.63, 131.04, 130.66, 130.40, 129.78, 129.46, 129.37, 128.12, 125.15, 124.46, 123.76, 123.28, 122.73, 122.63, 120.04, 119.87, 119.72, 41.62 164.69, 164.57, 164.13, 164.00, 163.60, 163.53, 163.27, 163.20, 162.59, 162.08, 162.02, 161.95, 161.47, 159.88, 159.50, 151.76, 151.71, 151.47, 151.30, 151.23, 150.43, 150.37, 150.05, 149.97, 149.61, 148.40, 148.32, 144.02, 140.94, 140.80, 140.77, 139.80, 139.62, 139.36, 139.32, 129.93, 129.83, 128.20, 124.84, 124.77, 124.74 
Bacterial strains and media
The Gram-negative Escherichia coli TOP10 strain (Invitrogen) was cultivated in Luria-Bertani (LB) medium (1% Tryptone, 0.5% yeast extract, 1% NaCl). Solid plates were prepared by adding 1.5%
agar. Deinococcus radiodurans, a red-pigmented Gram-positive bacterium, was grown in TGY medium (0.5% Tryptone, 0.1% glucose, 0.3% yeast extract), to which 1.5% of agar was added if necessary.
Disk diffusion test
A dilution (0. 
Bacterial growth curves
To prepare the inoculum of E. coli, a single colony was inoculated in 2 mL LB medium and cultivated at 37 °C under shaking for 15 h. The overnight pre-culture was diluted to 0.05 optical density at 600 nm (OD600nm) into Falcon tubes containing 5 mL of fresh medium and the growth was measured at appropriate time intervals using a plastic cuvette in a spectrophotometer were performed in DMSO. The rate of bacterial growth was measured as described before. 
X-ray crystallography
